HighTower Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
HighTower Advisors's ATRC Position: Q2 2026 in Review
HighTower Advisors opened a new position in AtriCure (ATRC) in Q2 2026: 8,490 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #3412 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in ATRC as recently as Q1 2015.
HighTower Advisors first reported a position in ATRC in Q3 2014 and has held it in 4 quarters since. The position peaked at $1.11M in Q1 2015. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- HighTower Advisors held 8,490 shares of AtriCure worth $238K as of Q2 2026.
- AtriCure was a new HighTower Advisors position in Q2 2026.
- AtriCure made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3412 holding.
- HighTower Advisors first reported a position in AtriCure in Q3 2014 and has held it in 4 quarters since.
- HighTower Advisors's AtriCure position peaked at $1.11M in Q1 2015.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.